| Maria C Olafsson, LCSW | |
|
2511 N 124th St Ste 106, Brookfield, WI 53005-4684 | |
| (262) 641-4347 | |
| (262) 641-4350 |
| Full Name | Maria C Olafsson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 2511 N 124th St Ste 106, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326069808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7677 (Wisconsin) | Primary |
| Entity Name | Systemic Perspectives Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497849152 PECOS PAC ID: 0446147847 Enrollment ID: O20040301001089 |
News Archive
International biotechnology firm Cytonet recently launched the first ever clinical trial in the United States using an investigational liver cell infusion to treat urea cycle disorders (UCD) in children. The first patient in the Phase II trial, which will seek to enroll 20 patients in 12 medical centers, is a child with citrullinemia, which is a hereditary UCD. He received six liver cell infusions on six consecutive days at Yale School of Medicine in New Haven, Conn.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria C Olafsson, LCSW 20440 Bartlett Dr, Brookfield, WI 53045-1718 Ph: (262) 993-1442 | Maria C Olafsson, LCSW 2511 N 124th St Ste 106, Brookfield, WI 53005-4684 Ph: (262) 641-4347 |
News Archive
International biotechnology firm Cytonet recently launched the first ever clinical trial in the United States using an investigational liver cell infusion to treat urea cycle disorders (UCD) in children. The first patient in the Phase II trial, which will seek to enroll 20 patients in 12 medical centers, is a child with citrullinemia, which is a hereditary UCD. He received six liver cell infusions on six consecutive days at Yale School of Medicine in New Haven, Conn.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 9 days ago
Heather Lynn Kindschy, LCSW-BACS Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 14755 W Capitol Dr Ste 100, Brookfield, WI 53005 Phone: 262-781-3065 | |
Renee L Genin, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2515 N 124th St, Suite 101, Brookfield, WI 53005 Phone: 262-641-4347 | |
Josie Jean Elmer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 20725 W North Avenue, Brookfield, WI 53045 Phone: 608-335-6441 | |
Elizabeth Kelly, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd Ste 200, Brookfield, WI 53005 Phone: 262-789-1191 | |
Kathleen Ward Jorgensen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1650 Hamilton Dr, Brookfield, WI 53045 Phone: 312-399-8688 | |
Ashley E Maas, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd Ste 305, Brookfield, WI 53005 Phone: 800-438-1772 Fax: 262-293-9737 | |
Damon William Buckett, LCSW MSSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 16535 W Bluemound Rd, Suite 200, Brookfield, WI 53005 Phone: 262-542-3255 |